Mainz Biomed N.V. (QUCY)
NASDAQ: QUCY · Real-Time Price · USD
0.6917
-0.0457 (-6.20%)
At close: Mar 16, 2026, 4:00 PM EDT
0.7001
+0.0084 (1.21%)
After-hours: Mar 16, 2026, 6:00 PM EDT

Mainz Biomed Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
0.660.890.90.530.580.49
Revenue Growth (YoY)
-28.05%-0.17%69.00%-8.22%16.98%75.40%
Cost of Revenue
0.210.320.390.350.40.37
Gross Profit
0.450.570.510.180.180.12
Selling, General & Admin
11.513.1517.5621.619.420.48
Research & Development
5.655.849.595.020.480.31
Other Operating Expenses
-0.28----
Total Operating Expenses
17.1519.2727.1526.639.90.8
Operating Income
-16.98-18.7-26.64-26.44-9.72-0.67
Interest Income
--0.25-0.340.09
Interest Expense
-0.63-1.08-0.56-0.29--0.18
Other Non-Operating Income (Expense)
-1.39-1.881.160.35-1.630.36
Total Non-Operating Income (Expense)
-2.02-2.960.850.06-1.290.27
Pretax Income
-19-21.65-26.3-26.39-11.69-0.59
Net Income
-18.97-21.65-26.3-26.39-11.69-0.59
Net Income to Common
-18.97-21.65-26.3-26.39-11.69-0.59
Shares Outstanding (Basic)
131210000
Shares Outstanding (Diluted)
131210000
Shares Change (YoY)
35.64%23.37%3227.40%-4.73%114.19%-
EPS (Basic)
15.24-1.84-2.69-63.50-38.93-4.19
EPS (Diluted)
15.24-1.84-2.69-63.50-38.93-4.19
EPS Growth
-11.29%-----
Free Cash Flow
-15.45-17.19-23.14-15.43-3.24-0.48
Free Cash Flow Per Share
-1.18-1.46-2.43-53.93--
Gross Margin
67.50%64.31%56.91%34.38%30.77%24.94%
Operating Margin
-2572.89%-2091.23%-2975.47%-4990.60%-1684.36%-136.50%
Profit Margin
-2874.69%-2421.80%-2936.50%-4979.90%-2024.79%-118.91%
FCF Margin
-2340.66%-1923.39%-2583.83%-2911.63%-560.67%-96.93%
EBITDA
-15.96-17.68-25.78-26.06-9.65-0.61
EBITDA Margin
-2418.33%-1977.47%-2878.71%-4918.92%-1672.25%-124.25%
EBIT
-16.98-18.7-26.64-26.44-9.72-0.67
EBIT Margin
-2572.89%-2091.23%-2975.47%-4990.60%-1684.36%-136.50%
Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q